A detailed history of Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Advisors, LLC holds 4,450 shares of ABBV stock, worth $864,546. This represents 0.16% of its overall portfolio holdings.

Number of Shares
4,450
Previous 4,450 -0.0%
Holding current value
$864,546
Previous $810,000 5.8%
% of portfolio
0.16%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $137 - $154
1 Added 0.02%
4,450 $689,000
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $26,050 - $30,156
-195 Reduced 4.2%
4,449 $663,000
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $3,577 - $4,452
-27 Reduced 0.58%
4,644 $625,000
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $433 - $499
3 Added 0.06%
4,671 $744,000
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $27,662 - $33,174
-200 Reduced 4.11%
4,668 $754,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $24,157 - $27,707
-180 Reduced 3.57%
4,868 $681,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $6,445 - $8,155
-60 Reduced 1.17%
5,048 $683,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $21,280 - $24,156
200 Added 4.07%
5,108 $551,000
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $10,521 - $11,721
-100 Reduced 2.0%
4,908 $553,000
Q1 2021

Apr 16, 2021

BUY
$102.3 - $112.62 $54,423 - $59,913
532 Added 11.89%
5,008 $542,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $10,061 - $13,583
-125 Reduced 2.72%
4,476 $480,000
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $6,643 - $10,072
103 Added 2.29%
4,601 $351,000
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $5,554 - $6,949
77 Added 1.74%
4,498 $398,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $344,174 - $424,460
4,421 New
4,421 $408,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Advisors, LLC Portfolio

Follow Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisors, LLC with notifications on news.